31
TITLE: Determinants of real estate bank profitability  Full Text
AUTHORS: Martins, AM; Serra, AP ; Stevenson, S;
PUBLISHED: 2019, SOURCE: RESEARCH IN INTERNATIONAL BUSINESS AND FINANCE, VOLUME: 49
INDEXED IN: Scopus WOS CrossRef: 24
32
TITLE: Madeira Island: Tourism, natural disasters and destination image
AUTHORS: de Almeida, AMM; Machado, LP;
PUBLISHED: 2019, SOURCE: Contributions to Economics
INDEXED IN: Scopus CrossRef: 3
IN MY: ORCID
33
TITLE: The Demand for Football in Portugal: New Insights on Outcome Uncertainty
AUTHORS: Antonio Miguel Martins; Susana Cro;
PUBLISHED: 2018, SOURCE: JOURNAL OF SPORTS ECONOMICS, VOLUME: 19, ISSUE: 4
INDEXED IN: Scopus WOS
34
TITLE: The importance of security for hostel price premiums: European empirical evidence
AUTHORS: Susana Cro; Antonio Miguel Martins;
PUBLISHED: 2017, SOURCE: TOURISM MANAGEMENT, VOLUME: 60
INDEXED IN: WOS
35
TITLE: Structural breaks in international tourism demand: Are they caused by crises or disasters?
AUTHORS: Susana Cro; Antonio Miguel Martins;
PUBLISHED: 2017, SOURCE: TOURISM MANAGEMENT, VOLUME: 63
INDEXED IN: WOS
36
TITLE: REAL ESTATE MARKET RISK IN BANK STOCK RETURNS: EVIDENCE FOR 15 EUROPEAN COUNTRIES
AUTHORS: Antonio Miguel Martins; Ana Paula Serra ; Francisco Vitorino Martins ;
PUBLISHED: 2016, SOURCE: INTERNATIONAL JOURNAL OF STRATEGIC PROPERTY MANAGEMENT, VOLUME: 20, ISSUE: 2
INDEXED IN: Scopus WOS CrossRef: 7
37
TITLE: INTERNATIONAL, RANDOMIZED, PLACEBO-CONTROLLED TRIAL OF CC-486 (ORAL AZACITIDINE) IN PATIENTS WITH IPSS INTERMEDIATE-1 MYELODYSPLASTIC SYNDROMES WITH RBC-TRANSFUSION-DEPENDENT ANEMIA AND THROMBOCYTOPENIA: THE QUAZAR LOWER-RISK MDS TRIAL  Full Text
AUTHORS: Garcia Manero, G; Platzbecker, U; Santini, V; Voso, MT; Garcia, R; Valcarcel, D; Silverman, LR; Almeida, A; Giagounidis, A; Larsen, SR; Kreitz, S; Hoenekopp, A; Skikne, BS;
PUBLISHED: 2015, SOURCE: 13th International Symposium on Myelodysplastic Syndromes (MDS) in LEUKEMIA RESEARCH, VOLUME: 39
INDEXED IN: WOS
IN MY: ORCID
38
TITLE: MDS-005 STUDY: EFFECT OF BASELINE ENDOGENOUS EPO ON RBC TRANSFUSION INDEPENDENCE (RBC-TI) IN LENALIDOMIDE-TREATED PATIENTS WITH LOW/INTERMEDIATE-1-RISK MDS WITHOUT DEL(5Q)  Full Text
AUTHORS: Santini, V; Li, JS; Swern, AS; Almeida, A; Giagounidis, A; Fu, T; Hoenekopp, A; Beach, CL; Skikne, B; Fenaux, P;
PUBLISHED: 2015, SOURCE: 13th International Symposium on Myelodysplastic Syndromes (MDS) in LEUKEMIA RESEARCH, VOLUME: 39
INDEXED IN: WOS
IN MY: ORCID
39
TITLE: 115 MDS-005 STUDY: EFFECT OF BASELINE ENDOGENOUS EPO ON RBC TRANSFUSION INDEPENDENCE (RBC-TI) IN LENALIDOMIDE-TREATED PATIENTS WITH LOW/INTERMEDIATE-1-RISK MDS WITHOUT DEL(5Q)
AUTHORS: Santini, V; J.S Li; A.S Swern; Almeida, A; Giagounidis, A; Fu, T; Hoenekopp, A; C.L Beach; Skikne, B; Fenaux, P;
PUBLISHED: 2015, SOURCE: Leukemia Research, VOLUME: 39
INDEXED IN: CrossRef: 2
IN MY: ORCID
40
TITLE: 100 INTERNATIONAL, RANDOMIZED, PLACEBO-CONTROLLED TRIAL OF CC-486 (ORAL AZACITIDINE) IN PATIENTS WITH IPSS INTERMEDIATE-1 MYELODYSPLASTIC SYNDROMES WITH RBC-TRANSFUSION-DEPENDENT ANEMIA AND THROMBOCYTOPENIA: THE QUAZAR LOWER-RISK MDS TRIAL
AUTHORS: Garcia-Manero, G; Platzbecker, U; Santini, V; M.T Voso; Garcia, R; Valcarcel, D; L.R Silverman; Almeida, A; Giagounidis, A; S.R Larsen; Kreitz, S; Hoenekopp, A; B.S Skikne;
PUBLISHED: 2015, SOURCE: Leukemia Research, VOLUME: 39
INDEXED IN: CrossRef
IN MY: ORCID
Page 4 of 6. Total results: 52.